Phase 1 Chronic Kidney Disease Clinical Trials
14 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–14 of 14 trials
Recruiting
Phase 1
A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD)
Regend Therapeutics15 enrolled1 locationNCT07275788
Recruiting
Phase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort
Chronic Kidney Disease
AstraZeneca124 enrolled5 locationsNCT07024823
Recruiting
Phase 1Phase 2
A Study to Learn How Safe and Tolerable Vonsetamig is in Adult Patients With Chronic Kidney Disease (CKD) Who Need Kidney Transplantation and Are Highly Sensitized to Human Leukocyte Antigen (HLA)
Chronic Kidney Disease(CKD)
Regeneron Pharmaceuticals56 enrolled10 locationsNCT05092347
Recruiting
Phase 1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
Chronic Kidney Disease
Novartis Pharmaceuticals112 enrolled1 locationNCT07235059
Recruiting
Phase 1Phase 2
A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease
Healthy VolunteersChronic Kidney Disease
Ingenia Therapeutics INC94 enrolled1 locationNCT07231679
Recruiting
Phase 1
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Chronic Kidney DiseasesEnd-stage Kidney DiseaseImmunological Tolerance+1 more
University of California, Los Angeles10 enrolled1 locationNCT05525507
Recruiting
Phase 1
Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
Chronic Kidney DiseasesRenal Transplantation
Qianfoshan Hospital30 enrolled1 locationNCT07045467
Recruiting
Phase 1Phase 2
Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease
Heart FailureChronic Kidney DiseasesKidney Diseases+1 more
Northwestern University60 enrolled1 locationNCT05719714
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability and PK of SK-08
Chronic Kidney Disease(CKD)
Consun Pharmaceutical Group48 enrolled1 locationNCT07021157
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for CKD
Chronic Kidney Diseases
The Foundation for Orthopaedics and Regenerative Medicine20 enrolled1 locationNCT05018845
Recruiting
Phase 1
Inflammation REduction to Prevent cArdiovascular Injury in Renal Disease (REPAIR)
Chronic Kidney DiseasesRenal Failure
Hamilton Health Sciences Corporation200 enrolled3 locationsNCT06203977
Recruiting
Phase 1
Sympatholysis in Chronic Kidney Disease
Chronic Kidney Disease
Emory University110 enrolled1 locationNCT02411773
Recruiting
Phase 1Phase 2
A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy with AION-301 Administered by Intravenous Infusion Compared with Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age with Chronic Kidney Disease (CKD)
Chronic Kidney Disease Stage 3
AION Healthspan, Inc.36 enrolled1 locationNCT06721143
Recruiting
Phase 1
Safety and Efficacy of KDSTEM Inj. in Patients With Chronic Kidney Disease
Chronic Kidney Diseases
EHL Bio Co., Ltd.6 enrolled1 locationNCT06071143